2704 related articles for article (PubMed ID: 18485271)
21. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
22. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.
Kew KM; Dias S; Cates CJ
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010844. PubMed ID: 24671923
[TBL] [Abstract][Full Text] [Related]
23. Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation.
Rhee CK; van Boven JFM; Yau Ming SW; Park HY; Kim DK; Park HS; Ling JZJ; Yoo KH; Price DB
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):934-942. PubMed ID: 30292924
[TBL] [Abstract][Full Text] [Related]
24. Vilanterol and fluticasone furoate for asthma.
Dwan K; Milan SJ; Bax L; Walters N; Powell C
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD010758. PubMed ID: 27582089
[TBL] [Abstract][Full Text] [Related]
25. Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study.
Sicras-Mainar A; Gómez Rodríguez B; Traseira-Lugilde S; Fernández-Sánchez T; Velasco Garrido JL
BMJ Open; 2022 Apr; 12(4):e053964. PubMed ID: 35443946
[TBL] [Abstract][Full Text] [Related]
26. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.
Kew KM; Dahri K
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011721. PubMed ID: 26798035
[TBL] [Abstract][Full Text] [Related]
27. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.
Ni Chroinin M; Greenstone I; Lasserson TJ; Ducharme FM
Cochrane Database Syst Rev; 2009 Oct; (4):CD005307. PubMed ID: 19821344
[TBL] [Abstract][Full Text] [Related]
28. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
Lee DK; Jackson CM; Currie GP; Cockburn WJ; Lipworth BJ
Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722
[TBL] [Abstract][Full Text] [Related]
29. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
30. Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation.
Müller V; Gálffy G; Eszes N; Losonczy G; Bizzi A; Nicolini G; Chrystyn H; Tamási L
BMC Pulm Med; 2011 Jul; 11():40. PubMed ID: 21762500
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
32. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
33. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
Chauhan BF; Ducharme FM
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003137. PubMed ID: 24459050
[TBL] [Abstract][Full Text] [Related]
34. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
35. Inhaled steroids with and without regular formoterol for asthma: serious adverse events.
Janjua S; Schmidt S; Ferrer M; Cates CJ
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD006924. PubMed ID: 31553802
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (pMDI).
Al-Ahmad M; Webb D
Respir Med; 2022 Apr; 194():106771. PubMed ID: 35180515
[TBL] [Abstract][Full Text] [Related]
37. High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids.
Paggiaro P; Corradi M; Latorre M; Raptis H; Muraro A; Gessner C; Siergiejko Z; Scuri M; Petruzzelli S
BMC Pulm Med; 2016 Dec; 16(1):180. PubMed ID: 27938358
[TBL] [Abstract][Full Text] [Related]
38. Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids.
Ahmad S; Kew KM; Normansell R
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011306. PubMed ID: 26089258
[TBL] [Abstract][Full Text] [Related]
39. Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review.
Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TSC
BMJ Evid Based Med; 2022 Jun; 27(3):178-184. PubMed ID: 34282031
[TBL] [Abstract][Full Text] [Related]
40. Adherence and usage patterns of inhaled corticosteroids-long-acting beta-agonists by using inhaler-monitoring technology.
Stanford RH; Averell CM; Johnson PT; Buysman EK; Carlyle MH
Allergy Asthma Proc; 2020 Jul; 41(4):256-264. PubMed ID: 32605696
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]